Clinical Trial Update: A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers. [Phase 1]

View source ↗

Summary

A Phase 1, single-centre randomized study assessed the safety and tolerability of GSK233705 in healthy volunteers, sponsored by GlaxoSmithKline. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK233705

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED